232632, BMS,
3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester,
atazanavir,
atazanavir sulfate,
BMS 232632,
BMS 232632 05,
BMS-232632,
BMS-232632-05,
BMS232632,
BMS23263205,
CGP 73547,
CGP 75136,
CGP 75176,
CGP 75355,
CGP-73547,
CGP-75136,
CGP-75176,
CGP-75355,
CGP73547,
CGP75136,
CGP75176,
CGP75355,
Reyataz,
Atazanavir sulfate,
229975-97-7,
Reyataz,
Atazanavir sulphate,
Atazanavir (sulfate),
BMS-232632-05,
UNII-4MT4VIE29P,
Atazanavir sulfate [USAN],
Atazanavir sulfate (BMS-232632-05),
4MT4VIE29P,
Reyataz (TN),
CHEBI:31243,
2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-, dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1) (salt),
2,5,6,10,13-Pentaazatetradecanedioic acid, 3-12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((-4-(2-pyridinyl)phenyl)methyl)-, dimethyl ester, (3S,8S,9S,12S)-, sulfate (1:1) (salt),
Dimethyl (3S,8S,9S,12S)-9-benzyl-3,12,di-tert-butyl-8-hydroxy-4,11-dioxo-6-(p-2-pyridylbenzyl)-2,5,6,10,13-pentaazatetradecanedioate, sulfate (1:1) (salt),
SMR002544693,
ulfuric acid,
AK-97253,
atazanavir; sulfuric acid,
BMS-232632 sulfate,
AC1L4K4Y,
MLS003915641,
MLS006010199,
SCHEMBL341700,
Atazanavir sulfate (JAN/USAN),
CHEMBL1200678,
AOB5599,
C38H52N6O7.H2SO4,
DQSGVVGOPRWTKI-QVFAWCHISA-N,
KS-00000FO1,
HY-17367A,
MFCD08067748,
s1457,
AKOS016000176,
CS-1890,
SB19157,
AS-14954,
BC677640,
N349,
AB0015721,
LS-186585,
FT-0662312,
ST24030092,
SW220258-1,
D01276,
Z-3316,
111996-EP2272516A2,
111996-EP2298761A1,
111996-EP2298783A1,
975A977,
J-014934,
methyl ((5S,10S,11S,14S)-11-benzyl-5-(tert-butyl)-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,8,12-tetraazahexadecan-14-yl)carbamate sulfate,
methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate; sulfuric acid,
methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate;s,
Zrivada,
Atazanavir,
Atazanavirsulfate,
BMS-232632,
C38H52N6O7.H2O4S,
CGP-73547,
CID158550,
ACN-029237,
CS-O-30486,
C38-H52-N6-O7.H2-O4-S,
A4040,
A10096,
Atazanavir sulfate, 99%, HIV protease inhibitors - 10MG 10mg,